ERA PerMed 2020 - Multidisciplinary research projects on personalised medicine - pre-/clinical research, big data and ICT, implementation and user's perspective

Personalized planning in radiotherapy through integrative modeling of local dose effect and new dosimetric constraints – PerPlanRT

Submission summary

Radiotherapy for prostate cancer (PC) involves irradiation not only of the target volume but also of portions of healthy neighboring Organs at Risk (OaR) such as bladder, rectum or penile bulb. RT-induced morbidity of sexual, urinary, or rectal nature can arise, impacting Quality of life (QoL). Predicting toxicities to devise personalized treatments with reduced RT-induced morbidity and maximized local control is a crucial question in RT. RT protocols are currently optimized on the former assumptions that the radio-sensitivity and the functionality are uniform within the same OaR. Image mining of 3D dose distribution in low spatial scales, by means of voxel-based methods, has highlighted the existence of radiosensitive sub-regions (SRR) responsible of radio-induced toxicity. Modern RT protocols have not yet incorporated these findings due to the lack of i) extensive validation ii) dosimetric constraints for plan optimization and iii) automated methods to contour these patient-specific SRR for quick generation of accurate and robust treatment plans.The goal of PerPlanRT is to devise innovative decision-making tools aimed at proposing integrated and feasible strategies for personalized RT in PC with reduced RT-induced toxicities (rectal, urinary, sexual) aimed at improving QoL. Multivariable spatially accurate predictive models derived from large set of cohorts prospectively collected will be applied to different RT scenarios (IMRT/VMAT, post-prostatectomy, hypofractionated, proton treatments, MRI-based RT) to explore their patient-specific benefits in depth. The application of these models to the clinical practice will be performed through the generation of dose distributions adapted to patient-specific anatomies. Guidelines will be proposed for designing prospective clinical trials. This translational approach will enable the transfer, for the first time, of innovative tools to the clinics and the implementation of validated findings from 3D voxel-wise analysis

Project coordination

Oscar ACOSTA (LABORATOIRE TRAITEMENT DU SIGNAL ET DE L'IMAGE)

The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.

Partner

IRCCS San Raffaele
Universidad Carlos III de Madrid
Clínica Universidad de Navarra (CUN)
Centre de lutte contre le cancer (CLCC) Eugène Marquis
Fondazione IRCCS Istituto Nazionale dei Tumori
LTSI LABORATOIRE TRAITEMENT DU SIGNAL ET DE L'IMAGE

Help of the ANR 297,000 euros
Beginning and duration of the scientific project: March 2021 - 36 Months

Useful links

Explorez notre base de projets financés

 

 

ANR makes available its datasets on funded projects, click here to find more.

Sign up for the latest news:
Subscribe to our newsletter